Table 7 Detailed toxicity analysis by pkCSM.

From: Exploring target selectivity in designing and identifying PI3Kα inhibitors for triple negative breast cancer with fragment-based and bioisosteric replacement approach

Compounds

Toxicity

Renal OCT2

substrate

(Yes/No)

AMES

toxicity

(Yes/No)

Max tolerated

dose (human)

(log mg/kg/day)

hERG I

inhibitor

(Yes/No)

hERG II inhibitor (Yes/No)

Oral rat

acute toxicity

(LD50) (mol/kg)

Oral Rat

Chronic

Toxicity (LOAEL)

(log mg/kg_bw/day)

Hepatotoxicity (Yes/No)

Skin Sensitisation (Yes/No)

T. Pyriformis toxicity (log μg/L)

Minnow toxicity (log mM)

Djh1

No

No

0.111

No

Yes

2.594

1.38

Yes

No

0.294

−0.016

10

No

No

0.287

No

Yes

2.303

1.469

Yes

No

0.289

0.01

06

No

No

0.098

No

Yes

2.591

1.356

Yes

No

0.299

0.172

Dhj2

No

Yes

0.147

No

Yes

2.78

1.899

Yes

No

0.304

2.2

08

No

Yes

−0.3

No

Yes

2.895

1.286

Yes

No

0.292

3.35

19

No

Yes

0.433

No

Yes

2.798

1.296

Yes

No

0.286

2.746

Inavolisib

No

Yes

0.044

No

Yes

2.507

1.269

Yes

No

0.285

2.434